All articles by GlobalData Healthcare

Neffy nasal spray: a game changer for asthma patients and epinephrine delivery?

The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in emergency treatment for type I…
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval

The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 monoclonal…
Physicians highlight need for improved non-opioid treatments for opioid use disorder

Opioids are synthetic or natural agents that stimulate opioid receptors in the brain and nervous system and are often used to…
Epigenetic drugs show 375% increase in Series A venture financing in 2024

The innovative epigenetic drugs space has witnessed a two-fold increase in Series A venture financing, with total deal value increasing…
FDA hits Ozempic and Mounjaro counterfeit compounders with warning letters

The US Food and Drug Administration (FDA) has sent numerous warning letters to compounding pharmacies for illegally selling semaglutide and…

ESMO 2024: Keytruda is key to first-line treatment of HER2+ mGEJ adenocarcinoma

Gastroesophageal junction carcinoma (GEJ) is a difficult-to-treat malignancy that constitutes a large minority of all gastric cancers. One of the…
ESMO 2024: TIGIT race tightens with first look at GSK/iTeos’s TIGIT in NSCLC

TIGIT inhibitors have long been in a difficult race toward the finish line on the non-small cell lung cancer (NSCLC)…
ESMO 2024: Enhertu to eclipse SOC for HER2+ breast cancer with brain metastases

The most common and deadliest malignancy among women is breast cancer (BC), with 2.3 million women diagnosed and 670,000 deaths…
EASD 2024: Are tetra-agonists the future of metabolic diseases treatment?

This first half of the week at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting 2024…
EASD 2024: Novel insights into maternal protection in T1D

At the European Association for the Study of Diabetes (EASD) 2024 conference, results were presented for a meta-analysis, shedding new…